Immunodiagnostics Market Size, Share, Growth Analysis, By Product(Instruments, Reagents & Consumables), By Application(Oncology & Endocrinology, Hepatitis & Retrovirus, Cardiac Markers, Infectious Diseases), By End User(Clinical Laboratories, Hospitals, Physician’s Offices, Others), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2401 | Region: Global | Published Date: October, 2024
Pages: 157 | Tables: 66 | Figures: 75

Immunodiagnostics Market News

In December 2023, American Laboratory Products Company Ltd. (ALPCO), a leading provider of diagnostic solutions announced the commercial launch of its Calprotectin Immunoturbidimetric Assay. The product has a FDA 510(k) clearance and this launched helped ALPCO expand its portfolio of Gastrointestinal (GI) diagnostic solutions.
In August 2023, Gold Colloid Co., a new company focused on the development and commercialization of rapid immunodiagnostic lateral flow tests was launched. The company is expected to innovate in the space of immunodiagnostics materials and services going forward.
In May 2021, PerkinElmer, a leading provider of diagnostic technologies and solutions signed an agreement to acquire Immunodiagnostic Systems (IDS) for USD 155 million in cash. Through this move PerkinElmer expanded its presence in the global immunodiagnostics industry.

Immunodiagnostics Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Immunodiagnostics Market size was valued at USD 23.2 billion in 2022 and is poised to grow from USD 24.17 billion in 2023 to USD 33.6 billion by 2031, growing at a CAGR of 4.20% during the forecast period (2024-2031).

Collaborations and acquisitions are projected to be popular strategies for immunodiagnostics companies looking to expand their business scope going forward. Investing in the development of novel immunodiagnostics products and instruments is also forecasted to create new opportunities for market players in the future. Investing in developing countries is projected to offer lucrative opportunities for immunodiagnostics providers in the long run. 'Abbott (US) ', 'Roche Diagnostics (Switzerland) ', 'DiaSorin (Italy) ', 'Danaher Corporation (US) ', 'QIAGEN (Netherlands) ', 'bioMérieux (France) ', 'Thermo Fisher Scientific (US) ', 'Quest Diagnostics (US) ', 'Siemens Healthineers AG (Germany) ', 'Bio-Rad Laboratories, Inc. (US) ', 'Sysmex Corporation (Japan) ', 'PerkinElmer, Inc. (US) ', 'Agilent Technologies, Inc. (US) ', 'Mindray Medical International Limited (China) ', 'Grifols, S.A. (Spain) ', 'Becton, Dickinson and Company (BD) (US) ', 'Abcam plc (UK) ', 'Merck KGaA (Germany) ', 'Enzo Biochem, Inc. (US) ', 'Bio-Techne Corporation (US) ', 'Meso Scale Diagnostics, LLC. (US) ', 'GenScript Biotech Corporation (China) ', 'Myriad Genetics, Inc. (US)'

Development of Multiplex Tests: Immunodiagnostics companies can invest in the development of multiplex tests that are capable of detecting several biomarkers to save time and resources. Growing demand for comprehensive diagnostics and screening in clinical settings is also forecasted to make this a prominent immunodiagnostics market trend for companies across the study period and beyond.

North America is predicted to spearhead the demand for immunodiagnostics in the world. High investments in medical R&D, high healthcare spending potential, and availability of favorable reimbursement policies are expected to be key factors promoting the demand for immunodiagnostics in this region. Moreover, rising adoption of home care and quick adoption of advanced diagnostic technologies are also expected to create new opportunities for immunodiagnostics companies in the long run. The United States and Canada are forecasted to emerge as the most opportune markets in the North American region. The presence of leading immunodiagnostics companies also allows this region to hold sway over the global immunodiagnostics market outlook through 2031.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Immunodiagnostics Market News

Immunodiagnostics Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Immunodiagnostics Market?

Who are the key vendors in the Immunodiagnostics Market?

What is the key driver of Immunodiagnostics Market?

What is the key market trend for Immunodiagnostics Market?

Which region accounted for the largest share in Immunodiagnostics Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300